Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Liyan Fan

Showing results (31-40 of 32) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 32 results.
Haematologica|February 5, 2026
Multicenter prospective phase II study of decitabine priming with low-dose idarubicin, cytarabine, and G-CSF in children with refractory or relapsed acute myeloid leukemiaLiyan Fan, Li Gao, Weina Zhang, et al.
Nature Communications|November 19, 2020
Myeloid Krüppel-like factor 2 is a critical regulator of metabolic inflammationDavid R Sweet, Neelakantan T Vasudevan, Liyan Fan, et al.
Pageof 4

Showing results (31-40 of 32) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 32 results.
Haematologica|February 5, 2026
Multicenter prospective phase II study of decitabine priming with low-dose idarubicin, cytarabine, and G-CSF in children with refractory or relapsed acute myeloid leukemiaLiyan Fan, Li Gao, Weina Zhang, et al.
Nature Communications|November 19, 2020
Myeloid Krüppel-like factor 2 is a critical regulator of metabolic inflammationDavid R Sweet, Neelakantan T Vasudevan, Liyan Fan, et al.
Pageof 4